X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (141) 141
female (139) 139
index medicus (138) 138
oncology (117) 117
middle aged (88) 88
obstetrics & gynecology (74) 74
adult (70) 70
aged (69) 69
ovarian cancer (60) 60
cancer (59) 59
chemotherapy (50) 50
surgery (41) 41
retrospective studies (40) 40
carcinoma (38) 38
ovarian neoplasms - pathology (36) 36
survival (32) 32
hematology, oncology and palliative medicine (31) 31
ovarian neoplasms - drug therapy (30) 30
analysis (29) 29
disease-free survival (29) 29
obstetrics and gynecology (29) 29
aged, 80 and over (28) 28
neoplasm staging (28) 28
cervical cancer (26) 26
treatment outcome (26) 26
women (25) 25
antineoplastic combined chemotherapy protocols - therapeutic use (22) 22
care and treatment (22) 22
ovarian neoplasms - surgery (22) 22
management (21) 21
prognosis (21) 21
gynecologic-oncology-group (20) 20
laparoscopy (19) 19
survival rate (19) 19
trial (19) 19
uterine cervical neoplasms - pathology (19) 19
neoadjuvant chemotherapy (18) 18
combined modality therapy (16) 16
follow-up studies (16) 16
hysterectomy (16) 16
metastasis (16) 16
pegylated liposomal doxorubicin (16) 16
prospective studies (16) 16
cisplatin (15) 15
endometrial cancer (15) 15
carboplatin (14) 14
bevacizumab (13) 13
recurrence (13) 13
research (13) 13
risk factors (13) 13
young adult (13) 13
antineoplastic agents - therapeutic use (12) 12
endometrial neoplasms - pathology (12) 12
health aspects (12) 12
lymph node excision (12) 12
lymphadenectomy (12) 12
medical research (12) 12
medicine, experimental (12) 12
ovarian neoplasms - mortality (12) 12
paclitaxel - administration & dosage (12) 12
carboplatin - administration & dosage (11) 11
chemotherapy, adjuvant (11) 11
neoplasm recurrence, local - pathology (11) 11
ovarian neoplasms (11) 11
paclitaxel (11) 11
therapy (11) 11
uterine cervical neoplasms - drug therapy (11) 11
uterine cervical neoplasms - surgery (11) 11
antineoplastic agents - adverse effects (10) 10
antineoplastic combined chemotherapy protocols - adverse effects (10) 10
carcinoma, ovarian epithelial (10) 10
clinical trials (10) 10
diagnosis (10) 10
lymphatic metastasis (10) 10
morbidity (10) 10
neoplasm recurrence, local - drug therapy (10) 10
outcomes (10) 10
ovarian neoplasms - therapy (10) 10
pharmacology & pharmacy (10) 10
platinum (10) 10
quality of life (10) 10
radiotherapy (10) 10
relapse (10) 10
uterine cervical neoplasms - therapy (10) 10
산부인과학 (10) 10
cancer patients (9) 9
disease progression (9) 9
diseases (9) 9
doxorubicin - administration & dosage (9) 9
endometrial neoplasms - surgery (9) 9
hematology (9) 9
italy (9) 9
kaplan-meier estimate (9) 9
laparoscopy - methods (9) 9
neoadjuvant therapy (9) 9
oncology, experimental (9) 9
ovarian neoplasms - genetics (9) 9
phase-ii (9) 9
adolescent (8) 8
cancer therapies (8) 8
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 4, pp. 396 - 405
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2016, Volume 375, Issue 22, pp. 2154 - 2164
Journal Article
International Journal of Gynecologic Cancer, ISSN 1048-891X, 02/2019, Volume 29, Issue 2, pp. 272 - 276
BackgroundCervical cancer is a common malignancy among women and, when recurring, presents a dismal prognosis. After platinum failure, second-line treatments... 
TRIAL | PERSISTENT | ONCOLOGY | BEVACIZUMAB | SQUAMOUS-CELL CARCINOMA | CANCER | OBSTETRICS & GYNECOLOGY
Journal Article
Journal Article
Minerva Ginecologica, ISSN 0026-4784, 10/2016, Volume 68, Issue 5, pp. 566 - 578
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 5, pp. 561 - 568
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 8, pp. 1137 - 1146
Journal Article
by Coleman, Robert L and Coleman, R L and Oza, Amit M and Oza, A M and Lorusso, D and Lorusso, Domenica and Aghajanian, C and Aghajanian, Carol and Oaknin, A and Oaknin, Ana and Dean, A and Dean, Andrew and Colombo, N and Colombo, Nicoletta and Weberpals, Johanne I and Weberpals, J I and Clamp, Andrew and Clamp, A and Scambia, Giovanni and Scambia, G and Leary, A and Leary, Alexandra and Holloway, Robert W and Holloway, R W and Gancedo, M Amenedo and Gancedo, Margarita Amenedo and Fong, Peter C and Fong, P C and Goh, Jeffrey C and Goh, J C and O'Malley, David M and O'Malley, D M and Armstrong, Deborah K and Armstrong, D K and Garcia-Donas, Jesus and Garcia-Donas, J and Swisher, E M and Swisher, Elizabeth M and Floquet, A and Floquet, Anne and Konecny, Gottfried E and Konecny, G E and McNeish, I A and McNeish, Iain A and Scott, C L and Scott, Clare L and Cameron, Terri and Maloney, Lara and Isaacson, Jeff and Goble, Sandra and Grace, Caroline and Harding, Thomas C and Raponi, Mitch and Sun, James and Lin, Kevin K and Giordano, Heidi and Ledermann, J A and Ledermann, Jonathan A and Buck, M and Friedlander, M L and Harnett, P and Kichenadasse, G and Denys, H and Dirix, L and Vergote, I and Elit, L and Ghatage, P and Plante, M and Provencher, D and Welch, S and Gladieff, L and Joly, F and Lortholary, A and Lotz, J and Medioni, J and Tredan, O and You, B and El-Balat, A and Hänle, C and Krabisch, P and Neunhöffer, T and Pölcher, M and Wimberger, P and Amit, A and Kovel, S and Leviov, M and Safra, T and Shapira-Frommer, R and Stemmer, S and Bologna, A and Pignata, S and Sabbatini, R F and Tamberi, S and Zamagni, C and O'Donnell, A and Herraez, A Casado and Guerra, E M and Palacio, I and Romero, I and Sanchez, A and ... and ARIEL3 Investigators and ARIEL3 investigators
The Lancet, ISSN 0140-6736, 10/2017, Volume 390, Issue 10106, pp. 1949 - 1961
Rucaparib, a poly(ADP-ribose) polymerase inhibitor, has anticancer activity in recurrent ovarian carcinoma harbouring a mutation or high percentage of... 
MEDICINE, GENERAL & INTERNAL | MULTICENTER | SOLID TUMORS | BEVACIZUMAB | OPEN-LABEL | CANCER | HETEROZYGOSITY | EPITHELIAL OVARIAN | CHEMOTHERAPY | Double-Blind Method | Follow-Up Studies | Risk Assessment | Humans | Middle Aged | Ovarian Neoplasms - pathology | Neoplasm Recurrence, Local - drug therapy | Survival Rate | Treatment Outcome | Ovarian Neoplasms - mortality | Neoplasm Recurrence, Local - mortality | Indoles - administration & dosage | Poly(ADP-ribose) Polymerase Inhibitors - administration & dosage | Neoplasm Recurrence, Local - pathology | Disease-Free Survival | Maintenance Chemotherapy - methods | Internationality | Ovarian Neoplasms - therapy | Female | Aged | Molecular Targeted Therapy - methods | Clinical trials | Care and treatment | Carcinoma | Drug therapy | Ovarian cancer | Cancer | Analysis | Chemotherapy | Ovarian carcinoma | Platinum | Biomarkers | Mutation | Cancer therapies | Tumors | Homologous recombination | Central nervous system | Poly(ADP-ribose) | Homology | Genomes | Fallopian tube | ADP | Anticancer properties | Metastases | Homologous recombination repair | Randomization | Pain | Motivation | Ribose | Hemoglobin | Alanine | Anemia | Poly(ADP-ribose) polymerase | Breast cancer | Patients | Survival | Heterozygosity | Abdomen | Polymerase | Inhibitors | Point mutation | Loss of heterozygosity | Antitumor activity | Aspartate aminotransferase | Peritoneum
Journal Article
The Lancet Oncology, ISSN 1470-2045, 12/2018, Volume 19, Issue 12, pp. e655 - e655
Journal Article
Recenti Progressi in Medicina, ISSN 0034-1193, 06/2017, Volume 108, Issue 6, pp. 265 - 268
Journal Article
Future Oncology, ISSN 1479-6694, 12/2013, Volume 9, Issue 12, pp. 26 - 27
Journal Article